STARTUP PROFILE

Atlas

COUNTRY
USA
FOUNDED
2021
CATEGORY
Consumer Neurotech
Developing a behind-the-ear EEG wearable that quantifies cognitive signals such as readiness and focus for real-world monitoring and performance contexts.
Visit website →

Track this company in Market Notes

Funding, launches and regulatory moves across the neurotech startup map, delivered every two weeks.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Non-dilutive
MODALITY
EEG
FORM FACTOR
Patch
INTERFACE DEPTH
Non-invasive
INDICATION
Wellness
TARGET USER
Consumers
REGULATORY STAGE
Non-medical
Atlas is positioned as a consumer EEG wearable emphasizing a discrete behind-the-ear form factor that avoids the headband aesthetic typical of competitors like Muse and BrainBit. The grant-funded, wellness-focused product targets behavioral feedback loops linking cognitive state to daily activity, though it remains pre-commercial with no disclosed regulatory or clinical pathway.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
8
FDA Supports the BCI Mission
18 August – 1 September 2026

Atlas opened pre-orders for the Atlas 1.0 after five years of development. Worn on the hairless skin behind the ear, the patch combines EEG with motion, skin conductance, and voice-vibration sensing to estimate three measures: Presence, Stress, and Energy Burn. Starting at $499 with a $29.99 monthly subscription, the San Francisco company is making a direct play for the mainstream wearable market held by Oura and Whoop, using a subscription model and simplified scores rather than clinical framing. Atlas has raised $24 million and was selected for the NBA Launchpad programme earlier this year.

Articles featuring
Atlas